Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 48, Issue 3, 2015, Pages 627-636

  Spalletta, Gianfranco ^a,b   Long, Jeffrey D ^c,d   Robinson, Robert G ^c   Trequattrini, Alberto ^e   Pizzoli, Sonia ^a   Caltagirone, Carlo ^a,f   Orfei, Maria D ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e ASL 1 Umbria   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alzheimer's disease; apathy; mortality; predictors; prognosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY DISORDER; APATHY; APPETITE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEATH; DELUSION; DYSPHORIA; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENOTYPE; HALLUCINATION; HUMAN; IRRITABILITY; LOCOMOTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORTALITY; NEUROPSYCHIATRY; PREDICTION; SLEEP DISORDER; GENETICS; KAPLAN MEIER METHOD; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; PSYCHOLOGY;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS;

EID: 84943784092     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150391     Document Type: Article

References (51)

1. Zanetti O, Solerte SB, Cantoni F (2009) Life expectancy in Alzheimer's disease (AD). Arch Gerontol Geriatr 49(Suppl 1), 237-243.
2. Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B (1998) Prognostic factors in very old demented adults: A seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 46, 444-452.
3. Wattmo C, Londos E, Minthon L (2014) Risk factors that affect life expectancy in Alzheimer's disease: A 15-year follow-up. Dement Geriatr Cogn Disord 38, 286-299.
4. Guehne U, Riedel-Heller S, Angermeyer MC (2005) Mortality in dementia. Neuroepidemiology 25, 153-162.
5. Rabins PV, Schwartz S, Black BS, Corcoran C, Fauth E, Mielke M, Christensen J, Lyketsos C, Tschanz J (2013) Predictors of progression to severe Alzheimer's disease in an incidence sample. Alzheimers Dement 9, 204-207.
6. Tsai PH, Chen SP, Lin KN, Wang PN, Wang HC, Liu CY, Hong CJ, Liu HC (2007) Survival of ethnic Chinese with Alzheimer's disease: A 5-year longitudinal study in Taiwan. J Geriatr Psychiatry Neurol 20, 172-177.
7. Vilalta-Franch J, Calvo-Perxas L, Garre-Olmo J, Turro-Garriga O, Lopez-Pousa S (2013) Apathy syndrome in Alzheimer's disease epidemiology: Prevalence, incidence, persistence, and risk and mortality factors. J Alzheimers Dis 33, 535-543.
8. Landes AM, Sperry SD, Strauss ME (2005) Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 17, 342-349.
9. Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: The role of depression and apathy. J Alzheimers Dis 20, 175-183.
10. Lee M, Chodosh J (2009) Dementia and life expectancy: What do we know? J Am Med Dir Assoc 10, 466-471.
11. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
12. Cummings JL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 48, S10-S16.
13. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314.
14. Katz S, Down T, Cash H, Grotz R (1970) Progress in the development of the index of ADL. Gerontologist 10, 20-30.
15. Lawton M, Brody E (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
16. Wulfsohn MS, Tsiatis AA (1997) A joint model for survival and longitudinal data measured with error. Biometrics 53, 330-339.
17. RCoreTeam. (2013) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria. http://www. R-project. org/.
18. Philipson P, Sousa I, Diggle P, Williamson P, Kolamunnage-Dona R, Henderson R (2012) joineR: Joint modelling of repeated measurements and time-to-event data, http:// CRAN. R-project. org/package=joineR.
19. RizopoulosD(2012) Joint Models for Longitudinal andTimeto-Event Data: With Applications in R. Chapman & Hall, Boca Raton, FL.
20. Efron B, TibshiraniR(1994)AnIntroduction to the Bootstrap, CRC Press.
21. Starkstein S, Jorge RE, MizrahiR(2006) The prevalence, clinical correlates and treatment of apathy in Alzheimer's disease. Eur J Psychiat 20, 96-106.
22. Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KA (2013) Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci 25, 302-307.
23. Mori T, Shimada H, Shinotoh H, Hirano S, Eguchi Y, Yamada M, Fukuhara R, Tanimukai S, Zhang MR, Kuwabara S, Ueno S, Suhara T (2014) Apathy correlates with prefrontal amyloid beta deposition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 85, 449-455.
24. Delrieu J, Desmidt T, Camus V, Sourdet S, Boutoleau-Bretonniere C, Mullin E, Vellas B, Payoux P, Lebouvier T (2014) Apathy as a feature of prodromal Alzheimer's disease: An FDG-PET ADNI study. Int J Geriatr Psychiatry 30, 470-477.
25. Tunnard C, Whitehead D, Hurt C, Wahlund LO, Mecocci P, Tsolaki M, Vellas B, Spenger C, Kloszewska I, Soininen H, Lovestone S, Simmons A (2011) Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry 26, 741-748.
26. Hahn C, Lim HK, WonWY, Ahn KJ, Jung WS, LeeCU(2013) Apathy and white matter integrity in Alzheimer's disease: A whole brain analysis with tract-based spatial statistics. PLoS One 8, e53493.
27. Chen CS, Yeh YC, Chang YS, Huang MF (2011) Plasma homocysteine level and apathy in Alzheimer's disease. J Am Geriatr Soc 59, 1752-1754.
28. Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P (2006) Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Acta Psychiatr Scand 113, 59-63.
29. Peters BD, Blaas J, de HaanL(2010) Diffusion tensor imaging in the early phase of schizophrenia: What have we learned? J Psychiatr Res 44, 993-1004.
30. Sterniczuk R, Theou O, Rusak B, Rockwood K (2013) Sleep disturbance is associated with incident dementia and mortality. Curr Alzheimer Res 10, 767-775.
31. Ju YE, Lucey BP, HoltzmanDM(2014) Sleep and Alzheimer disease pathology-a bidirectional relationship. Nat Rev Neurol 10, 115-119.
32. Nagata T, Shinagawa S, Ochiai Y, Kada H, Kasahara H, Nukariya K, Nakayama K (2010) Relationship of frontal lobe dysfunction and aberrant motor behaviors in patients with Alzheimer's disease. Int Psychogeriatr 22, 463-469.
33. Tekin S, Mega MS, Masterman DM, Chow T, Garakian J, Vinters HV, Cummings JL (2001) Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol 49, 355-361.
34. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA (2004) Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 140, 501-509.
35. Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF (2001) Mortality with dementia: Results from a French prospective community-based cohort. Am J Epidemiol 154, 642-648.
36. Brookmeyer R, Corrada MM, Curriero FC, Kawas C (2002) Survival following a diagnosis of Alzheimer disease. Arch Neurol 59, 1764-1767.
37. Llinas-Regla J, Lopez-Pousa S, Vilalta-Franch J, Garre-Olmo J, Roman GC (2008) Mortality after a diagnosis of dementia in a population aged 75 and over in Spain. Neuroepidemiology 31, 80-88.
38. Prince HM, Duvic M, Martin A, SterryW, Assaf C, Straus DJ (2012) Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sezary syndrome receiving placebo. J Am Acad Dermatol 67, 867-875.
39. Roe CM, Xiong C, Miller JP, Morris JC (2007) Education and Alzheimer disease without dementia: Support for the cognitive reserve hypothesis. Neurology 68, 223-228.
40. Piras F, Cherubini A, Caltagirone C, Spalletta G (2011) Education mediates microstructural changes in bilateral hippocampus. Hum Brain Mapp 32, 282-289.
41. Stern Y (2009) Cognitive reserve. Neuropsychologia 47, 2015-2028.
42. Sylvestre MP, Huszti E, Hanley JA (2006) Do OSCAR winners live longer than less successful peers? A reanalysis of the evidence. Ann Intern Med 145, 361-363; discussion 392.
43. Shariff SZ, Cuerden MS, Jain AK, GargAX(2008) The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 19, 841-843.
44. Little DM, Crooks VC, Petitti DB, Chiu V, Schellenberg GD, Slezak JM, Jacobsen SJ (2009) Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States. J Am Geriatr Soc 57, 231-236.
45. Starkstein SE, Petracca G, Chemerinski E, Kremer J (2001) Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 158, 872-877.
46. Robert P, Onyike CU, Leentjens AF, Dujardin K, Aalten P, Starkstein S, Verhey FR, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J (2009) Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 24, 98-104.
47. Peters ME, Rosenberg PB, Steinberg M, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner J, Tschanz JT, Lyketsos CG(2013) Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The Cache County Study. Am J Geriatr Psychiatry 21, 1116-1124.
48. Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, Lyketsos CG (2015) Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: The cache county dementia progression study. Am J Psychiatry 172, 460-465.
49. Aalten P, Jolles J, de Vugt ME, Verhey FR (2007) The influence of neuropsychological functioning on neuropsychiatric problems in dementia. J Neuropsychiatry Clin Neurosci 19, 50-56.
50. Jeste DV, Finkel SI (2000) Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 8, 29-34.
51. Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD (2002) Provisional diagnostic criteria for depression of Alzheimer disease: Rationale and background. Am J Geriatr Psychiatry 10, 129-141.